[ad_1]
Russia has already approved two vaccines for use, including Sputnik V, developed by the Gamalay Institute. Both vaccines have also been approved in the absence of results from late-stage clinical trials. This has caused concern to some Western scientists.
The Sputnik V vaccine was approved in the country in August and late-stage clinical trials began in September. The mass vaccination was launched in December, and preliminary results show that the vaccine is 91.4% effective.
Since then, at least the first dose of the vaccine has been given to more than 2 million people. Russian, February 10, said the country’s health minister, Mikhail Murashko.
Russia is also slowly rolling out a coronavirus vaccine developed by the Vektor Institute near Novosibirsk.
“Russia is the only country today that has three COVID-19 vaccines,” Prime Minister Mishustin said.
The third vaccine approved in the country was developed in 1955. The Chumakov Science Center, known for its collaboration with the American scientist Albert Sabin, with whom he developed a widely used polio vaccine, was established in Saint Petersburg.
Unlike the Sputnik V vaccine, which uses a modified influenza virus that ‘tricks’ the body into forming antibodies to help prepare for a coronavirus infection, CoviVac uses the coronavirus itself, but only a weakened version that is not can reproduce.
“The vaccine that we have developed … reflects the entire history of vaccine science in Russia, as well as in the world,” Aidar Izmukametov, director of the Chumakov Science Center, said on Saturday.
CoviVac is given in two doses 14 days apart. It can be transported and stored at normal refrigerator temperatures ranging between 2 and 8 degrees Celsius, said Deputy Prime Minister Tatiana Golikova in January.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
